What is ArriVent BioPharma, Inc.'s stock issuance proceeds?

ArriVent BioPharma, Inc. (AVBP) reported stock issuance proceeds of $54.72M in Q1 2026.

How has ArriVent BioPharma, Inc.'s stock issuance proceeds changed year-over-year?

ArriVent BioPharma, Inc.'s stock issuance proceeds increased by 739.8% year-over-year, from $6.52M to $54.72M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

ArriVent BioPharma, Inc. AVBP Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Nuvation BioNUVB

$908K-16.1%

ImmunomeIMNM

$229K+7.5%

Arcus BiosciencesRCUS

$0-100%

Erasca, Inc.ERAS

$258.75M+783,991%

Bicara TherapeuticsBCAX

$161.76M—

ImmunityBio, Inc.IBRX

$971K+341%

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Reported directly by ArriVent BioPharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s stock issuance proceeds?: ArriVent BioPharma, Inc. (AVBP) reported stock issuance proceeds of $54.72M in Q1 2026.
How has ArriVent BioPharma, Inc.'s stock issuance proceeds changed year-over-year?: ArriVent BioPharma, Inc.'s stock issuance proceeds increased by 739.8% year-over-year, from $6.52M to $54.72M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.